Asian chronic kidney disease best practice recommendations: positional statements for early detection of chronic kidney disease from Asian Forum for Chronic Kidney Disease Initiatives (AFCKDI).

摘要

Patients with chronic kidney disease (CKD) are at increased risk of progression to end stage kidney disease and cardiovascular disease if they are not identified and properly managed. This is true for all patients with CKD. Despite the increasing prevalence of CKD in Asia, there are few guidelines for early detection of CKD in Asian countries.Although there is broad agreement about targeted screening directed at subgroups of the population who would derive the most benefit from CKD detection, there are differing views regarding the costs and benefits of a population wide surveillance programme. Table 1 summarizes the existing international guidelines on screening for CKD. There are no randomized controlled trials examining outcomes of kidney disease screening programmes (including cardiovascular risk), and little information specifically dealing with the issues of cost-effectiveness and public health policies. Recommendations have been- reported by the 2006 Kidney Disease Improving Global Outcomes (KDIGO) Controversies Conference regarding strategies for implementation of screening and surveillance for CKD in developing countries.